Pharmeasy Unlisted Share Price 2025

Our  Company was incorporated as ‘API Holdings Private Limited’ of incorporation March 31, 2019 We operate an integrated, end-to-end business that aims to provide solutions for health care needs of consumers across the following

We operate an integrated, end-to-end business that aims to provide solutions for healthcare needs of consumers across the following:

• delivering healthcare products including medicines, nutraceuticals, OTC and devices
• offering diagnostics and radiology tests, and
• offering technology products to stakeholders

Our in house supply chain capabilities, custom-built proprietary technology, and deep understanding of India’s healthcare market enable us to provide each stakeholder in the healthcare value-chain, viz:

• channel (wholesalers, retailers and chemists /institutions).
• consultants (and hospitals).
• consumers.
• companies (pharmaceutical, nutraceutical and others)

with supply chain infrastructure, diagnostics capabilities and technology tools while also enabling them to benefit from an interconnected network. Our platforms have scaled across urban, semiurban and rural India, with an ability to serve people across income groups and geographies.

We are building India’s largest OPD healthcare platform

Operating 4 primary business verticals : 

Pharmeasy plus Pharmeasy Lads : 4.2 Cr + Registered Customers.

Retailio: India’s Largest B2B Pharma Ecosystem for Pharmacies/ Chemists, Distributors/ Wholesalers/ Stockists and Manufacturers – all connected via Retailio.1.13 lacs Active Retailers in FY24 .

Aknamed:1,342 Hospitals Serviced in FY24.

Thyrocare: 4.5 lacsInvestigations Carried out on Daily basis.

Our Products and Services

Distribution to Retailer: We sell pharmaceutical, OTC, surgical, consumables and private label products procured from pharmaceutical companies, manufacturers, and wholesalers to retailers across the country through a technology powered platform.

Distribution to Chemist/Institutions and Distribution to Hospitals : We operate a technology-powered distribution business under which we procure pharmaceutical, OTC, surgical, consumablesfrom pharmaceutical companies and sell to local chemists and institutions, which include large pharmacies, hospitals, doctors, clinics, and medical centers across the country.

Diagnostic services: Thyrocare offers a comprehensive portfolio of more than 700+ Diagnostics tests through 31 diagnostic labs as of March 2023. 

We have 20 NABL Accredited labs as of March 2023 (vs 6 NABL labs in Fiscal 2022) as we increasingly emphasize On quality. 

We offer this service to franchise partners, consumers, hospitals, diagnostic companies, and independent phlebotomists. 

Consumers can avail Our diagnostics services by walking into a collection center, calling helplines for home collection, or booking a test online (including through
PharmEasy marketplace, Thyrocare’s website and other third-party online channels).

Retailio 3P Services: RetailiO provides technology Which Enables wholesalers and pharmacies to connect and sell a wide range of pharma and other medical products. 

Retailio is digitising the traditional pharma supply chain (via digital ordering, logistics and payments,) and empowering pharmacies with technology products.

It is available as a mobile app and web application. Retailio provides pharmacies with Real time price discovery, Inventory visibility and provides technology enabling ordering, confirmation and payments in a digitized, self-serve manner. 

For The Month of March 2023, 112,849 pharmacies and 5,229 wholesalers used Retailio to fulfil their procurement needs.

Retailio was used in more than 330 cities across India for The Month of March 2023.

Software services for doctors, consumers, and pharmacies: We provide EMR and practice management software and teleconsultation tools to doctors
through our proprietary software called Docon. 

We also provide teleconsultation services to customers on Docon mobile application and on PharmEasy marketplace. 22.4 million digital prescriptions were generated during Fiscal 2023 on our platform respectively. 

we facilitated 4.9 million e-Consultations during this period. For the month of March 2023,our technology tools were being used by 3,403 prescribing doctors to digitally engage with their patients.

Fulfilment and technology services for PharmEasy: We provide last mile fulfilment services to Axelia Solutions Private Limited for pharmaceutical and OTC products sold on PharmEasy marketplace. 

We also license the “PharmEasy” brand name and provide franchisor services, such as fulfilment, marketing and digital enablement for franchisee owned and operated offline pharmacies. 

We serviced more than 17,000 pin-codes across India for the month of March 2023.

Building a large product distribution business with a Pan-India Pharmacy and Hospital Network

We define GMV as follows: (i) For our products and services (other than Retailio 3P), GMV refers to our revenue for such products and services as per our books of accounts, grossed up for applicable taxes, (ii) for Retailio 3P, GMV refers to the gross merchandise value of products and services transacted using Retailio (excluding Retailio 1P GMV).

Building India’s leading diagnostics business leveraging the capabilities of Thyrocare and scaling the unique cross sell opportunity and cost advantages.

We provide diagnostics services to customers of PharmEasy marketplace through our brand PharmEasy Labs and have strengthened the processing capability and geographic reach of this business. 

Thyrocare offers a comprehensive portfolio of more than 700 diagnostics tests through 31 diagnostic labs as of March 31, 2023. 

We offer this service to franchise partners, consumers, hospitals, diagnostic companies, and independent phlebotomists. 

Consumers can avail our diagnostics services by walking into a collection center, callinghelplines for home collection, Booking a test online (including through PharmEasy marketplace, Thyrocare’s mobile application and website and other third-party online channels).

Pharmeasy Unlisted Share Price Details

Pharmeasy Unlisted Share Price Financial Details